Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
Matthew Feldman,* Sarah Marmol,* Jason Margolesky Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA*These authors contributed equally to this workCorrespondence: Jason Margolesky, Department of Neurology, University of Miami Miller School...
Main Authors: | Feldman M, Marmol S, Margolesky J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/updated-perspectives-on-the-management-of-drug-induced-parkinsonism-di-peer-reviewed-fulltext-article-TCRM |
Similar Items
-
Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report
by: Alexey A. Tappakhov, et al.
Published: (2020-06-01) -
Treatment of antipsychotic-induced parkinsonism in schizophrenic patients
by: E. E. Vaiman, et al.
Published: (2021-08-01) -
Atypical Antipsychotic-Induced Parkinsonism: A Patient Case with CYP Enzyme Implications
by: Carla Dolci Figura, et al.
Published: (2017-04-01) -
Management of drug-induced movement disorders in psychiatry: an update
by: Sekh Afrar Alam, et al.
Published: (2016-07-01) -
Drug-induced parkinsonism: what should a psychiatrist know?
by: Santiago Vásquez-Builes, et al.
Published: (2021-10-01)